EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature-Reference-Cited by-同舟云学术

EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature

Published:2015-09-13 Issue:2 Volume:205 Page:143-154
ISSN:0300-8584
Container-title:Medical Microbiology and Immunology
language:en
Short-container-title:Med Microbiol Immunol

Author:

Nejati Ahmad,Shoja Zabihollah,Shahmahmoodi Shohreh,Tafakhori Abbas,Mollaei-Kandelous Yaghoub,Rezaei Farhad,Hamid Kabir Magaji,Mirshafiey Abbas,Doosti Rozita,Sahraian Mohammad Ali,Mahmoudi Mahmood,Shokri Fazel,Emery Vince,Marashi Sayed Mahdi

Funder

Tehran University of Medical Sciences and Health Services (IR)

Tehran University of Medical Sciences, international Campus

Bonyad Melli Nokhbegan

Publisher

Springer Science and Business Media LLC

Subject

Microbiology (medical),Immunology,General Medicine,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00430-015-0437-7.pdf

Reference73 articles.

1. Nylander A, Hafler DA (2012) Multiple sclerosis. J Clin Invest 122:1180–1188

2. Bove R, Chitnis T (2014) The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis. Mult Scler 20:520–526

3. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517

4. Dyment DA, Ebers GC, Sadovnick AD (2004) Genetics of multiple sclerosis. Lancet Neurol 3:104–110

5. Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A et al (2013) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 45:1353–1360

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No Association between Single-Nucleotide Polymorphisms of The S1PR1 Gene or Interleukin-17 Levels with Fingolimod Response in A Small Group of Iranian Relapsing-Remitting Multiple Sclerosis Patients: A Case-Control Study;CELL J;2024

2. Vitamin D Supplementation: Effect on Cytokine Profile in Multiple Sclerosis;Journal of Clinical Medicine;2024-02-01

3. Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic Review;Multiple Sclerosis and Related Disorders;2023-12

4. Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review;Frontiers in Immunology;2022-11-02

5. The role of human endogenous retroviruses (HERVs) in Multiple Sclerosis and the plausible interplay between HERVs, Epstein–Barr virus infection, and vitamin D;Multiple Sclerosis and Related Disorders;2022-01